22
Views
29
CrossRef citations to date
0
Altmetric
Miscellaneous

Recently reported inhibitors of cyclooxygenase-2

Pages 21-29 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jeffery S Carter. (2000) Inhibitors of cyclooxygenase-2: November 1999 - April 2000. Expert Opinion on Therapeutic Patents 10:7, pages 1011-1020.
Read now
Amit S Kalgutkar. (1999) Selective cyclooxygenase-2 inhibitors as non-ulcerogenic anti-inflammatory agents. Expert Opinion on Therapeutic Patents 9:7, pages 831-849.
Read now

Articles from other publishers (27)

Amany Belal & Mohamed A. Abdelgawad. (2017) New benzothiazole/benzoxazole-pyrazole hybrids with potential as COX inhibitors: design, synthesis and anticancer activity evaluation. Research on Chemical Intermediates 43:7, pages 3859-3872.
Crossref
Chen-Ming Tan, Grace Shiahuy Chen, Chien-Shu Chen, Pei-Teh Chang & Ji-Wang Chern. (2011) Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry 19:21, pages 6316-6328.
Crossref
Rossella Fioravanti, Adriana Bolasco, Fedele Manna, Francesca Rossi, Francisco Orallo, Francesco Ortuso, Stefano Alcaro & Roberto Cirilli. (2010) Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. European Journal of Medicinal Chemistry 45:12, pages 6135-6138.
Crossref
Gökçen Eren, Serdar Ünlü, Maria-Teresa Nuñez, Luis Labeaga, Francisco Ledo, Antonio Entrena, Erden Banoğlu, Gabriele Costantino & M. Fethi Şahin. (2010) Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry 18:17, pages 6367-6376.
Crossref
Zhiqiang Feng, Fengming Chu, Zongru Guo & Piaoyang Sun. (2009) Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib. Bioorganic & Medicinal Chemistry Letters 19:8, pages 2270-2272.
Crossref
Afshin Zarghi, Samaneh Kakhgi, Atefeh Hadipoor, Bahram Daraee, Orkideh G. Dadrass & Mehdi Hedayati. (2008) Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors. Bioorganic & Medicinal Chemistry Letters 18:4, pages 1336-1339.
Crossref
Subas M. Sakya, Andrei Shavnya, Hengmiao Cheng, Chao Li, Bryson Rast, Jin Li, David A. Koss, Burton H. Jaynes, Donald W. Mann, Carol F. Petras, Scott B. Seibel, Michelle L. Haven & Michael P. Lynch. (2008) Comparative structure–activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition. Bioorganic & Medicinal Chemistry Letters 18:3, pages 1042-1045.
Crossref
Andrew Smellie. (2007) General Purpose Interactive Physico-Chemical Property Exploration. Journal of Chemical Information and Modeling 47:3, pages 1182-1187.
Crossref
Subas M. Sakya, Xinjun Hou, Martha L. Minich, Bryson Rast, Andrei Shavnya, Kristin M.L. DeMello, Hengmiao Cheng, Jin Li, Burton H. Jaynes, Donald W. Mann, Carol F. Petras, Scott B. Seibel & Michelle L. Haven. (2007) 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: Molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile. Bioorganic & Medicinal Chemistry Letters 17:4, pages 1067-1072.
Crossref
Jörg Degen & Matthias Rarey. (2006) FlexNovo: Structure-Based Searching in Large Fragment Spaces. ChemMedChem 1:8, pages 854-868.
Crossref
Hengmiao Cheng, Kristin M. Lundy DeMello, Jin Li, Subas M. Sakya, Kazuo Ando, K. Kawamura, Tomoki Kato, Robert J. Rafka, Burton H. Jaynes, Carl B. Ziegler, Rod Stevens, Lisa A. Lund, Donald W. Mann, Carolyn Kilroy, Michelle L. Haven, Erik L. Nimz, Jason K. Dutra, Chao Li, Martha L. Minich, Nicole L. Kolosko, Carol Petras, Annette M. Silvia & Scott B. Seibel. (2006) Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 16:8, pages 2076-2080.
Crossref
Subas M. Sakya, Hengmiao Cheng, Kristin M. Lundy DeMello, Andrei Shavnya, Martha L. Minich, Bryson Rast, Jason Dutra, Chao Li, Robert J. Rafka, David A. Koss, Jin Li, Burton H. Jaynes, Carl B. Ziegler, Donald W. Mann, Carol F. Petras, Scott B. Seibel, Annette M. Silvia, David M. George, Anne Hickman, Michelle L. Haven & Michael P. Lynch. (2006) 5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure–activity relationship studies of 5-alkylethers and 5-thioethers. Bioorganic & Medicinal Chemistry Letters 16:5, pages 1202-1206.
Crossref
Subas M. Sakya, Kristin M. Lundy DeMello, Martha L. Minich, Bryson Rast, Andrei Shavnya, Robert J. Rafka, David A. Koss, Hengmiao Cheng, Jin Li, Burton H. Jaynes, Carl B. Ziegler, Donald W. Mann, Carol F. Petras, Scott B. Seibel, Annette M. Silvia, David M. George, Lisa A. Lund, Suzanne St. Denis, Anne Hickman, Michelle L. Haven & Michael P. Lynch. (2006) 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure–activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog. Bioorganic & Medicinal Chemistry Letters 16:2, pages 288-292.
Crossref
Manojit Pal, Nalivela Kumara Swamy, P.Shahul Hameed, Srinivas Padakanti & Koteswar Rao Yeleswarapu. (2004) A rapid and direct access to symmetrical/unsymmetrical 3,4-diarylmaleimides and pyrrolin-2-ones. Tetrahedron 60:18, pages 3987-3997.
Crossref
Jin Li, Kristin M.Lundy DeMello, Henry Cheng, Subas M. Sakya, Brian S. Bronk, Robert J. Rafka, Burton H. Jaynes, Carl B. Ziegler, Carolyn Kilroy, Donald W. Mann, Eric L. Nimz, Michael P. Lynch, Michelle L. Haven, Nicole L. Kolosko, Martha L. Minich, Chao Li, Jason K. Dutra, Bryson Rast, Rhonda M. Crosson, Barry J. Morton, Glen W. Kirk, Kathleen M. Callaghan, David A. Koss, Andrei Shavnya, Lisa A. Lund, Scott B. Seibel, Carol F. Petras & Annette Silvia. (2004) Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine. Bioorganic & Medicinal Chemistry Letters 14:1, pages 95-98.
Crossref
H.X. Liu, R.S. Zhang, X.J. Yao, M.C. Liu, Z.D. Hu & B.T. Fan. (2004) QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines. Journal of Computer-Aided Molecular Design 18:6, pages 389-399.
Crossref
Tanja Schulz-Gasch & Martin Stahl. (2003) Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. Journal of Molecular Modeling 9:1, pages 47-57.
Crossref
Sabine Barbey, Laurence Goossens, Thierry Taverne, Joséphine Cornet, Valérie Choesmel, Céline Rouaud, Gilles Gimeno, Sylvie Yannic-Arnoult, Catherine Michaux, Caroline Charlier, Raymond Houssin & Jean-Pierre Hénichart. (2002) Synthesis and Activity of a New Methoxytetrahydropyran Derivative as Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitor. Bioorganic & Medicinal Chemistry Letters 12:5, pages 779-782.
Crossref
Hiromasa Hashimoto, Kimiya Maeda, Koichi Ozawa, Jun-ichi Haruta & Korekiyo Wakitani. (2002) 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 12:1, pages 65-68.
Crossref
Dimitra Kovala-Demertzi. (2000) Transition metal complexes of diclofenac with potentially interesting anti-inflammatory activity. Journal of Inorganic Biochemistry 79:1-4, pages 153-157.
Crossref
Zhihua Sui, Jihua Guan, Michael P. Ferro, Kathy McCoy, Michael P. Wachter, William V. Murray, Monica Singer, Michele Steber, Dave M. Ritchie & Dennis C. Argentieri. (2000) 1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2. Bioorganic & Medicinal Chemistry Letters 10:6, pages 601-604.
Crossref
Sharon M. Dankwardt. 2000. High Throughput Screening for Novel Anti-Inflammatories. High Throughput Screening for Novel Anti-Inflammatories 1 17 .
Jeffery S. Carter, D.J. Rogier, Matthew J. Graneto, Karen Seibert, Carol M. Koboldt, Yan Zhang & John J. Talley. (1999) Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 9:8, pages 1167-1170.
Crossref
Jeffery S. Carter, Steven Kramer, John J. Talley, Thomas Penning, Paul Collins, Matthew J. Graneto, Karen Seibert, Carol M. Koboldt, Jaime Masferrer & Ben Zweifel. (1999) Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 9:8, pages 1171-1174.
Crossref
Martin Beuck. (1999) Nichtsteroidale Antirheumatika: Generationswechsel bei den Cyclooxygenase-Inhibitoren. Angewandte Chemie 111:5, pages 663-666.
Crossref
John J. Talley. 1999. 201 234 .
Alison M. Badger & Jerry L. Adams. 1998. 203 212 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.